Astrana Health (NASDAQ:ASTH) Stock Price Down 4.8% – Here’s Why

by · The Markets Daily

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) shares traded down 4.8% on Wednesday . The stock traded as low as $36.32 and last traded at $36.4710. 137,474 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 501,517 shares. The stock had previously closed at $38.29.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Truist Financial upped their target price on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research report on Friday, May 8th. BTIG Research restated a “buy” rating and issued a $50.00 price objective on shares of Astrana Health in a research report on Tuesday, June 2nd. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Finally, TD Cowen upped their price objective on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $45.00.

Get Our Latest Stock Analysis on ASTH

Astrana Health Stock Down 1.2%

The company has a market cap of $2.11 billion, a P/E ratio of 61.95 and a beta of 1.00. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The firm’s 50 day moving average price is $33.98 and its 200-day moving average price is $27.19.

Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company’s revenue for the quarter was up 55.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.42 EPS. As a group, equities research analysts expect that Astrana Health, Inc. will post 1.25 EPS for the current year.

Institutional Trading of Astrana Health

Hedge funds have recently modified their holdings of the company. Signaturefd LLC raised its position in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after acquiring an additional 388 shares during the period. GAMMA Investing LLC raised its position in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares during the period. Strs Ohio bought a new stake in shares of Astrana Health in the 4th quarter valued at $40,000. Tower Research Capital LLC TRC increased its position in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares in the last quarter. Finally, State of Wyoming bought a new stake in shares of Astrana Health in the 2nd quarter valued at $132,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Recommended Stories